Telo Genomics Corp. (TSXV:TELO)
Canada flag Canada · Delayed Price · Currency is CAD
0.0500
+0.0050 (11.11%)
At close: Mar 9, 2026

Telo Genomics Ratios and Metrics

Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
51114212126
Upgrade
Market Cap Growth
-51.89%-20.24%-34.29%-1.32%-17.06%159.35%
Upgrade
Enterprise Value
51013201824
Upgrade
Last Close Price
0.050.110.180.290.360.50
Upgrade
PB Ratio
-9.0821.3623.388.048.176.96
Upgrade
P/TBV Ratio
-21.9924.978.178.257.11
Upgrade
Debt / Equity Ratio
-0.29--0.010.020.01
Upgrade
Net Debt / Equity Ratio
-0.20-1.53-1.35-1.01-1.02-0.98
Upgrade
Net Debt / EBITDA Ratio
-0.040.290.300.951.303.02
Upgrade
Net Debt / FCF Ratio
-0.060.340.320.981.463.23
Upgrade
Quick Ratio
0.082.062.208.7514.3732.85
Upgrade
Current Ratio
0.142.252.459.0914.6633.09
Upgrade
Return on Equity (ROE)
-438.32%-492.06%-169.42%-108.16%-67.12%-47.97%
Upgrade
Return on Assets (ROA)
-119.74%-179.64%-87.33%-61.11%-39.44%-31.26%
Upgrade
Return on Capital Employed (ROCE)
548.50%-523.80%-460.70%-107.80%-79.60%-33.60%
Upgrade
Earnings Yield
-52.18%-24.71%-19.67%-13.44%-9.92%-4.17%
Upgrade
FCF Yield
-39.66%-21.20%-17.87%-12.86%-8.56%-4.34%
Upgrade
Buyback Yield / Dilution
-36.09%-22.92%-18.67%-2.54%-25.11%-56.67%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.